United States · FDA National Drug Code directory
topiramate
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 65841-651_c45924d5-c45b-4f31-afa5-0cbc090d2816
- Product NDC
- 65841-651
- Form
- CAPSULE, COATED PELLETS
- Composition / generic term
- topiramate
- Labeler
- Zydus Lifesciences Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20091014
- Source listing expiry
- 20261231
Source-listed ingredients
- TOPIRAMATE — 15 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 CAPSULE, COATED PELLETS in 1 BOTTLE (65841-651-01) · 65841-651-01
- 500 CAPSULE, COATED PELLETS in 1 BOTTLE (65841-651-05) · 65841-651-05
- 1000 CAPSULE, COATED PELLETS in 1 BOTTLE (65841-651-10) · 65841-651-10
- 60 CAPSULE, COATED PELLETS in 1 BOTTLE (65841-651-14) · 65841-651-14
- 90 CAPSULE, COATED PELLETS in 1 BOTTLE (65841-651-16) · 65841-651-16
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →